AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Dequalinium Chloride
7 registrations across 4 African markets— 6 active
Markets with Dequalinium Chloride
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| FLUOMIZIN Vaginal tablet | 🇷🇼Rwanda | ROTTENDORF PHARMA GMBH | active | Aug 2029 |
| Dequadin Lozenges Lozenge | 🇳🇬Nigeria | Evans Baroque Limited | active | Jul 2028 |
| Fluomizin@ Vaginal Tablet | 🇰🇪Kenya | Dafra Pharma GmbH | active | Jun 2028 |
| DEQUACETS | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | Feb 2022 |
| FLUOMIZIN VAGINAL TABLET | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| FLUSIN LOZENGES | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| DEQUADIN MOUTH PAINT | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
Dequalinium Chloride in Africa — Regulatory Overview
Dequalinium Chloride is registered across 4 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Kenya, Nigeria, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 6 (86%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.